Chelsea Therapeutics International Ltd.
) was a big mover last session, as the company saw its shares rise
by over 11% on the day. The move came on solid volume too with far
more shares changing hands than in a normal session. This continues
the recent uptrend for the company, as the stock is now up 21.4%
over the past one-month time frame.
The company has seen 2 positive revisions in the past 30 days and
the Zacks Consensus Estimate has moved north over the same time
frame, suggesting that more solid trading could be ahead for
Chelsea Therapeutics. So, be sure to keep an eye on this stock,
going forward, to see if yesterday's improvement can turn into more
strength down the road.
Chelsea Therapeutics currently has a Zacks Rank #3 (Hold) while its
Some better performing biomedical stocks include
AMAG Pharmaceuticals, Inc.
Acorda Therapeutics, Inc.
). While Actelion and AMAG carry a Zacks Rank #1 (Strong Buy),
Acorda Therapeutics holds a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days
Click to get this free report >>
ACORDA THERAPT (ACOR): Free Stock Analysis
ACTELION LTD (ALIOF): Get Free Report
AMAG PHARMA INC (AMAG): Free Stock Analysis
CHELSEA THERAP (CHTP): Free Stock Analysis
To read this article on Zacks.com click here.